Edition:
United Kingdom

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

1,065JPY
17 May 2019
Change (% chg)

¥6 (+0.57%)
Prev Close
¥1,059
Open
¥1,069
Day's High
¥1,075
Day's Low
¥1,060
Volume
62,500
Avg. Vol
96,383
52-wk High
¥1,642
52-wk Low
¥983

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -- March 18 May 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 11,484.00 11,484.00 11,484.00 --
Year Ending Mar-19 1 48,500.00 48,500.00 48,500.00 --
Year Ending Mar-20 1 54,500.00 54,500.00 54,500.00 --
Year Ending Mar-21 1 57,500.00 57,500.00 57,500.00 --
Earnings (per share)
Year Ending Mar-19 1 58.40 58.40 58.40 --
Year Ending Mar-20 1 62.00 62.00 62.00 --
Year Ending Mar-21 1 143.40 143.40 143.40 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 11,484.00 9,690.00 1,794.00 15.62
Quarter Ending Dec-18 12,623.00 13,539.00 916.00 7.26
Quarter Ending Sep-18 11,539.00 10,716.00 823.00 7.13
Quarter Ending Jun-18 12,500.00 12,761.00 261.00 2.09

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 11,484.00 -- -- -- --
Year Ending Mar-19 48,500.00 -- -- -- --
Year Ending Mar-20 54,500.00 52,500.00 52,500.00 52,500.00 --
Year Ending Mar-21 57,500.00 56,300.00 56,300.00 56,300.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 -- -- -- --
Year Ending Mar-19 -- -- -- --
Year Ending Mar-20 1 0 1 0
Year Ending Mar-21 1 0 1 0
Earnings